AIN't That the Flu Med? A Rare Case of Tamiflu-Induced Acute Interstitial Nephritis (AIN)

Introduction: Tamiflu is commonly prescribed for the treatment of influenza. It is considered a safe drug for short-term use; however, rarely, its metabolite, oseltamivir carboxylate, can accumulate and cause acute kidney injury in patients with known renal disease. We report a case of a 74-year-old male with biopsy-proven AIN following Tamiflu use. Case Description: A 74-year-old male, with chronic kidney disease (CKD stage 3b with baseline creatinine-1.5) and hypertension, presented with anuria for two days. The patient stated that he had had a week of myalgias and fevers preceding the development of anuria, for which his primary care office had prescribed Tamiflu 75 mg twice a day, of which he took three doses, which he stopped taking due to anuria. He denied any hematuria, dysuria, other new medication usage, back, or abdominal pain. Labs showed a creatinine of 9.5 and a BUN of 83. Urinalysis was significant for moderate proteinuria, small hematuria, no casts, no pyuria, and no eosinophiluria. A Foley catheter was inserted over 24 hours, confirming anuria. Renal ultrasound revealed no evidence of obstruction. Serum creatinine continued to worsen over the next 3 days, reaching a peak of 13.5, at which point the patient was started on hemodialysis. Due to the unclear etiology of acute renal failure, a renal biopsy was obtained, which revealed AIN. Prednisone therapy was initiated. Over the next two weeks, urine output and serum creatinine improved to 3.5, and hemodialysis was stopped and the patient was discharged. On follow-up one month later, his kidney function had returned to baseline. Discussion: AIN is a rarely reported adverse event associated with Tamiflu use. Recognizing this potential adverse effect is crucial for prompt discontinuation of the drug and corticosteroid initiation to prevent permanent renal damage. This case also emphasizes the importance of renal dosing of Tamiflu in patients with CKD.Renal biopsy showing peritubular neutrophils

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025td13j6gk
Primary Topic
Nephrotoxicity and Medicinal Plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AIN't That the Flu Med? A Rare Case of Tamiflu-Induced Acute Interstitial Nephritis (AIN)

Sumayya Umar, Nuthan Bhat, Rakesh Mahali, E. J. Lewis
Journal of the American Society of Nephrology
Nephrotoxicity and Medicinal Plants
article

AIN't That the Flu Med? A Rare Case of Tamiflu-Induced Acute Interstitial Nephritis (AIN)

Sumayya Umar, Nuthan Bhat, Rakesh Mahali, E. J. Lewis
article en

Abstract

Introduction: Tamiflu is commonly prescribed for the treatment of influenza. It is considered a safe drug for short-term use; however, rarely, its metabolite, oseltamivir carboxylate, can accumulate and cause acute kidney injury in patients with known renal disease. We report a case of a 74-year-old male with biopsy-proven AIN following Tamiflu use. Case Description: A 74-year-old male, with chronic kidney disease (CKD stage 3b with baseline creatinine-1.5) and hypertension, presented with anuria for two days. The patient stated that he had had a week of myalgias and fevers preceding the development of anuria, for which his primary care office had prescribed Tamiflu 75 mg twice a day, of which he took three doses, which he stopped taking due to anuria. He denied any hematuria, dysuria, other new medication usage, back, or abdominal pain. Labs showed a creatinine of 9.5 and a BUN of 83. Urinalysis was significant for moderate proteinuria, small hematuria, no casts, no pyuria, and no eosinophiluria. A Foley catheter was inserted over 24 hours, confirming anuria. Renal ultrasound revealed no evidence of obstruction. Serum creatinine continued to worsen over the next 3 days, reaching a peak of 13.5, at which point the patient was started on hemodialysis. Due to the unclear etiology of acute renal failure, a renal biopsy was obtained, which revealed AIN. Prednisone therapy was initiated. Over the next two weeks, urine output and serum creatinine improved to 3.5, and hemodialysis was stopped and the patient was discharged. On follow-up one month later, his kidney function had returned to baseline. Discussion: AIN is a rarely reported adverse event associated with Tamiflu use. Recognizing this potential adverse effect is crucial for prompt discontinuation of the drug and corticosteroid initiation to prevent permanent renal damage. This case also emphasizes the importance of renal dosing of Tamiflu in patients with CKD.Renal biopsy showing peritubular neutrophils

Journal of the American Society of NephrologyVol. 36(10S)
St. Vincent's Medical Center (US)
Openalex Percentile: Top 48%
Nephrotoxicity and Medicinal Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.